Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Stanley Usen a Medical Research Council Laboratories, PO
Box 273, Fajara, Gambia, b Global Programme on
Vaccine and Immunisation, World Health Organisation, 1211 Geneva 27, Switzerland, c London School
of Hygiene and Tropical Medicine, London WC1E 7HT
Correspondence to: Dr Usen
susen{at}mrc.enda.sn
| |
Abstract |
|---|
|
|
|---|
Objectives:
To determine clinical correlates and
outcome of hypoxaemia in children admitted to hospital with an
acute lower respiratory tract infection.
Design:
Prospective cohort study.
Setting:
Paediatric wards of the Royal Victoria
Hospital and the hospital of the Medical Research Council's hospital
in Banjul, the Gambia.
Subjects:
1072 of 42 848 children, aged 2 to 33 months, who were enrolled in a randomised trial of a Haemophilus
influenzae type b vaccine in the western region of the Gambia,
and who were admitted with an acute lower respiratory tract infection
to two of three hospitals.
Main outcome measures:
Prevalence of hypoxaemia,
defined as an arterial oxygen saturation <90% recorded by pulse
oximetry, and the relation between hypoxaemia and aetiological agents.
Results:
1072 children aged 2-33 months were enrolled. Sixty three (5.9%) had an arterial oxygen saturation <90%. A
logistic regression model showed that cyanosis, a rapid respiratory
rate, grunting, head nodding, an absence of a history of fever, and no
spontaneous movement during examination were the best independent predictors of hypoxaemia. The presence of an inability to cry, head
nodding, or a respiratory rate
90 breaths/min formed the best
predictors of hypoxaemia (sensitivity 70%, specificity 79%). Hypoxaemic children were five times more likely to die than
non-hypoxaemic children. The presence of malaria parasitaemia had no
effect on the prevalence of hypoxaemia or on its association with
respiratory rate.
Conclusion:
In children with an acute lower
respiratory tract infection, simple physical signs that require minimal
expertise to recognise can be used to determine oxygen therapy and to
aid in screening for referral. The association between hypoxaemia and
death highlights the need for early recognition of the condition and
the potential benefit of treatment.
|
Key messages
|
| |
Introduction |
|---|
|
|
|---|
Acute lower respiratory tract infections are a major cause of morbidity and mortality among children in developing countries, accounting for about 30% of mortality in children under 5 years of age. 1 2 Most of these deaths occur at home before children enter the healthcare system.3
Use of simple algorithms for the case management of children with acute
lower respiratory tract infections has resulted in a significant
reduction in mortality from pneumonia.4 Oxygen therapy
improves the outcome of children with moderate or severe acute lower
respiratory tract infection and, in those with hypoxaemia, the severity
of hypoxia correlates with outcome.
5 6
However, in
countries with limited resources
for example, the Gambia
oxygen is
not always freely available. Thus it is important to have rational guidelines both for the use of oxygen and for the referral of patients
to specialist hospitals.
Pulse oximetry is a non-invasive and accurate method of measuring
arterial oxygen saturation.7 It is a useful predictor of
hypoxaemia and pneumonia.
8 9
Pulse oximeters are,
however, not available in most health centres in developing countries. For this reason clinical signs that best predict pneumonia, hypoxaemia, or mortality have been evaluated in earlier
studies.
6 10-13
No single sign has been found to be a
reliable predictor of hypoxaemia. Cyanosis is the most specific
predictor and the best clinical correlate of arterial oxygen
saturation, but it is difficult to detect.
6 8 13-19
In
some studies, mainly those undertaken at high
altitude,
6 8 9 17
a rapid respiratory rate was found useful as a predictor of hypoxaemia, but this was not the case in all
studies.
15 20
Moreover, children with malaria and
anaemia, who are not necessarily hypoxaemic, may present with a rapid
respiratory rate that is attributable to fever or cardiac failure. In
order to clarify further the predictive value of clinical signs in
hypoxaemia, a Kenyan study used a logistic regression model. This study
found that the presence of chest retraction, a respiratory rate
70 breaths/min, or grunting were the best predictors of
hypoxaemia.6 Chest retractions have been found useful as a
predictor of hypoxaemia in children with
bronchiolitis.
15 16
In an earlier study from the Gambia,
we found that the combination of cyanosis, head nodding (visible
movement of the head with each inspiration), and not crying during
examination identified over a half of hypoxaemic children.21 The study was, however, small and the
investigators were not blinded to one of the two control groups. We
analysed data collected during a large trial of a vaccine for the
prevention of infant pneumonia, to study further which clinical signs
predict hypoxaemia.
| |
Subjects and methods |
|---|
|
|
|---|
Selection criteria
Our study was undertaken in the context of an efficacy trial of a
Haemophilus influenzae type b (Hib) conjugate vaccine in
the western region of the Gambia from March 1993 to December
1995.22 During the course of the trial, 42 848 infants (about 90% of children resident in the study area) were enrolled when
they presented to a vaccination clinic for routine immunisation at the
age of 2 months. If any of the children in the trial cohort presented
to two of three study hospitals, they were evaluated by one of our
study physicians for features compatible with an invasive bacterial
disease. Children in whom this was considered a possible diagnosis were
managed appropriately. Children in the trial cohort who were eligible
for inclusion in our study were those admitted with pneumonia or any
other form of acute lower respiratory tract infection to either the
MRC's hospital at Banjul
a primary and secondary healthcare
institution serving a periurban population
or to the Royal Victoria
Hospital
the main referral hospital in the Gambia's capital, Banjul.
We excluded children aged <2 months (they were too young to be
enrolled in the vaccine trial), those with signs of structural heart
disease, those with Down's syndrome, and those who had been included
in a previous case-control study of hypoxaemia. As almost all children
resident in the study area were enrolled in the vaccine trial, and as
no other selection criteria were imposed, it is likely that the
children included in our study were representative of children in the
local community with acute lower respiratory tract infections. As it is
unlikely that Hib vaccination would influence the association between
clinical signs and hypoxaemia, this variable was not included in analyses.
Protocol
Our physicians recorded signs and symptoms using standardised
forms. Training sessions were held before and throughout the study
period to ensure uniformity of record keeping between observers.
Mothers were asked first about their children's symptoms and then
questioned on the presence of specific symptoms such as cough, fever,
refusal to feed or drink, rapid or difficult breathing, abnormal
sleepiness, arousability, or irritability. The physician then examined
the child for cyanosis, impaired consciousness, inability to eat or
drink, chest retraction, head nodding, grunting, and the presence of
wheeze, rhonchi, crepitations, or bronchial breath sounds. The
physician documented the child's respiratory rate, pulse rate, weight,
and height. On admission the child's arterial oxygen saturation was
measured with an appropriately sized sensor and a Nellcor N200 pulse
oximeter (Hayward, CA, USA) placed on a toe or finger, while the
patient breathed room air. The measurement selected was that which had
been stable for at least three minutes. Further measurements of
arterial oxygen saturation were undertaken as part of the management of
children whose clinical condition deteriorated or who received oxygen
therapy. Blood samples were taken from all children in the trial
cohort. These samples were cultured. Lung aspiration was performed when
chest x rays showed consolidation adjacent to the chest
wall, and pleural aspirations were done in cases of pleural effusion.
Nasopharyngeal aspirates were obtained from children admitted on a
working day, and these were examined for respiratory syncytial virus by
immunofluorescence.23 Chest x rays,
obtained whenever possible, were assessed at the end of the study by
one of the physicians (SU, MW, AO, CO, KM) who did not know the
clinical details of the case. The classification of parenchymal changes
has been described previously.21
Statistical analysis
We compared discrete clinical signs between hypoxaemic and
non-hypoxaemic children by using the
2 test with Yates
correction, or by using Fisher's exact test if the frequencies were
small. We compared continuous variables by using Student's
t test or a Wilcoxon rank sum test, as appropriate. Signs and symptoms that showed a significant association with hypoxaemia in the univariate analyses at a significance level of
0.05, together with those that had been reported as important predictors in previous literature, were included in multivariate logistic regression analyses that assessed their independent utility in
predicting hypoxaemia. We repeated modelling using variables in the
categories of complaints, general status, respiratory signs, and other
signs. For each category we built up models consecutively, starting
with the most significant variable, until no further variables reached
significance. We then removed variables from the multivariate model one
at a time to see if they remained significant in the presence of all
other variables. We then investigated together significant and
independent predictors of hypoxaemia identified in each category, from
which we acquired a final set of predictors. We compared different
models with one another by change in deviance. We then calculated the
diagnostic values of various combinations of the variables identified
in the logistic regression modelling, and others that had been reported
in the literature. For the analysis we used EPI Info version 6 and
SAS for Windows.
| |
Results |
|---|
|
|
|---|
Characteristics of the study population
Two thousand and ninety seven (4.9%) of the 42 848 children were
evaluated by our study physicians, 1114 (53.1%) of whom were
considered to have an acute lower respiratory tract infection that
required hospital admission. We excluded 23 (2.1%) children who had
either congenital heart disease or Down's syndrome, and 19 (1.7%)
children who had been enrolled in a previous case-control study. The
remaining 1072 (96.2%) children form the basis of this analysis. Sixty
three (5.9%) children had hypoxaemia.
Aetiological agents and hypoxaemia
One hundred and seventy seven invasive bacterial isolates were
identified from the 1072 children. Streptococcus pneumoniae was the most commonly isolated pathogen and was
found in 8.5% (n=91) of the children. H influenzae type
b was isolated from 2.2% (n=24) of the children, Staphylococcus
aureus from 2.1% (n=23), Salmonella spp from
1.2% (n=13), and H influenzae non-type b from 0.6%
(n=6). Pneumococci were isolated from 10 of the 63 (15.8%) hypoxaemic
children and from 81 of the 1009 (8.1%) non-hypoxaemic children
(P=0.05). The isolation rates of other bacteria did not differ
significantly between hypoxaemic and non-hypoxaemic children.
Malaria and hypoxaemia
Blood films were examined for malaria parasites in 1040 (97.0%)
children. Malaria parasitaemia was found in similar proportions of
children who were hypoxaemic (4/60, 6.7%) and non-hypoxaemic (103/980,
10.5%) (P=0.5). Neither the presence of pallor nor a temperature
38°C was associated significantly with hypoxaemia (14/63 (22.2%)
versus 161/1009 (15.0%); relative risk 1.39, 95% confidence interval
0.86 to 2.26, P=0.13 and 49/63 (77.8%) versus 817/1009 (81.0); 0.96, 0.84 to 1.10, P=0.6 respectively).
Symptoms and signs associated with hypoxaemia
Univariate analysis
The box shows the symptoms and signs evaluated in the children. Of
the complaints volunteered by mothers, only the absence of a history of
fever had a significant association with hypoxaemia; a history of fever
was volunteered by 946 of the 1009 (93.7%) mothers of non-hypoxaemic
children and 52 of 63 (83%) mothers of hypoxaemic children (P=0.001).
A history of cough, fast breathing, difficulty in breathing, diarrhoea,
vomiting, abdominal pain, chest pain, or convulsions was reported
spontaneously with a similar frequency for both hypoxaemic and
non-hypoxaemic children. No mother volunteered a history of bluish
discoloration of their child's tongue or nail beds.
|
Variables analysed as predictors of hypoxaemia in children
admitted with an acute lower respiratory tract infection
Complaints Examination Other signs: |
|
Sensitivity and specificity of clinical signs
Table 1 shows the sensitivity and specificity of signs and
symptoms in hypoxaemic and non-hypoxaemic children that were
significantly associated with hypoxaemia. Head nodding was found to be
a useful sign (sensitivity 57%, specificity 85%). Cyanosis, an
inability to feed or cry, abnormal sleepiness, and no spontaneous
movement during examination were specific but relatively insensitive signs.
In a regression model, no
spontaneous movement during examination (odds ratio 2.8, 95%
confidence interval 1.5 to 5.0), head nodding (2.9, 1.6 to 5.3),
cyanosis (4.6, 2.3 to 9.3), a respiratory rate
70 breaths/min
(2.4, 1.4 to 4.3), grunting (3.0, 1.3 to 6.8), and an absence of a
history of fever (3.1, 1.4 to 6.7) were independent and significant
predictors of hypoxaemia.
|
We tested various combinations of signs described in the
literature for their ability to predict hypoxaemia in our data set. In
addition, we tested combinations of the significant independent
predictors established in the regression analysis of our data set. In
our setting with limited resources, a model with a high specificity is
desirable. The presence of either cyanosis or head nodding was the most
specific predictor. This model would have missed 20 out of 63 (31.7%)
hypoxaemic children, and its absence correctly identified eight out of
10 children who were not hypoxaemic. The addition of other signs, as in
our earlier study, improved the sensitivity but compromised the
specificity of our model.21 Table 2 shows the results of
these models. Because of difficulty in assessing cyanosis, we combined
signs other than cyanosis until we obtained the most specific model that also identified the majority of hypoxaemic children. The presence
of either head nodding, an inability to cry, or a respiratory rate
90 breaths/min formed the best predictor. This model would have
missed 19 out of 63 (30.2%) hypoxaemic children of whom three (15.8%)
were cyanosed, four (21.0%) had grunting respiration, and five
(26.3%) had pneumonia detected by radiology. One of these children
died. Using this model, 216 of the 1009 (20.1%) children whose
arterial oxygen saturation was
90% would have received oxygen, 17 (7.9%) of whom were cyanosed, 50 (23.2%) had grunting respiration, 31 (14.4%) had a positive blood culture result, and 12 (5.6%) died. Thus
many of these children were severely ill and might have benefited from
oxygen therapy, even though one of their arterial oxygen saturation
measurements was
90%.
| |
Discussion |
|---|
|
|
|---|
Pneumonia is a serious disease in children, and hypoxaemia is the best indicator of both severe and potentially fatal pneumonia.6 Prompt recognition of hypoxaemia and supplemental oxygen therapy improves the outcome in severe pneumonia.5 Our study has shown that certain signs and symptoms in children with acute lower respiratory tract infections can be used to predict hypoxaemia. A rapid respiratory rate has been evaluated for predicting hypoxaemia or pneumonia in previous studies. 6 8-10 17 A rapid respiratory rate, however, is likely to be affected by altitude and the presence of anaemia or fever, so its use as a predictor of hypoxaemia in a malaria endemic area needs to be considered with caution.20 Our study found that the presence of malaria parasitaemia, pallor, or fever had no effect on the relation between respiratory rate and hypoxaemia. Respiratory rate remained a useful predictor of hypoxaemia in a malaria endemic area, but the prevalence of parasitaemia in our predominantly urban population was low.
We found that several physical signs that could be taught easily to health workers and mothers were more closely associated with hypoxaemia than auscultatory signs. Cyanosis, a rapid respiratory rate, grunting, an inability to feed, impaired consciousness, head nodding, not crying during examination, and hepatomegaly >2 cm were significantly associated with hypoxaemia. These signs used alone, however, were either not sufficiently sensitive or not specific. Cyanosis is a useful sign of hypoxaemia, but it is an infrequent, late, and subtle sign that can easily be missed in the presence of anaemia and in pigmented races. 14 18 Cyanosis is an ominous sign when present.19 In contrast, head nodding, which is caused by using the accessory muscles of respiration, is easily recognisable. This study, as well our previous study, found head nodding to be a useful sign. In the present study, it identified over half the children who were hypoxaemic, and its absence identified about nine out of 10 children who were not hypoxaemic.21 It may be argued that head nodding is useful as a predictor of hypoxaemia only in young children with acute lower respiratory tract infections, since it is an uncommon sign in children older than 5 years. Because head nodding is easily recognisable, however, it is a valuable sign in an age group that is most susceptible to hypoxaemia.
Since there are minimal adverse effects associated with oxygen therapy, it can be argued that in settings with adequate resources a very sensitive test is required. However, in many developing countries, oxygen therapy is expensive and available only in urban referral centres. It costs about US$10 (£6) per day to maintain one child on oxygen therapy at a flow rate of 1 l/min. This is a cost many countries cannot afford. For this reason, careful decisions about oxygen therapy and referral are required to avoid overburdening the referral system and depleting scarce oxygen supplies. In settings such as the Gambia, with limited resources, guidelines requiring high specificity are desirable because of the potential costs. It is also valuable to have guidelines based on practical and easily recognisable signs.
Our study was performed on a cohort of children who were under close
surveillance for H influenzae type b disease, and this may explain partially the low prevalence of hypoxaemia in the study
population and the lower mortality rate than that observed in a Kenyan
study.6 Moreover, we excluded infants <2 months of age,
as they were too young to be included in the vaccine trial, and they
may have been more prone to hypoxaemia. As in Kenya, a hypoxaemic child
in the Gambia is five times more likely to die than a non-hypoxaemic
child. Thus there is a need for the early recognition of signs of
hypoxaemia and prompt treatment. Our model of cyanosis, a respiratory
rate
70 breaths/min, grunting, head nodding, an absence of a history
of fever, and no spontaneous movement during examination, was the best
predictor of hypoxaemia. The combination of head nodding and cyanosis
identified seven out 10 hypoxaemic children, and its absence correctly
identified four out of five non-hypoxaemic children, thereby minimising
wastage of a precious resource. The addition of any other sign, as in our previous study, improved sensitivity but compromised specificity. The current recommendations for use of oxygen as suggested by the World
Health Organisation would have led to two out of five children
receiving oxygen when they did not have hypoxaemia.21 A
combination of four signs for predicting hypoxaemia, as used in Papua
New Guinea, performed as well as our model from the
Gambia.21 Both Kenyan models, however, which had high
sensitivities but low specificities, would have led to a high wastage
of oxygen.6 All models had very low predictive values,
which show the limitation of using clinical signs and also the low
prevalence of hypoxaemia in the study population. The poor predictive
value of clinical signs and poor agreement between observers are major
limitations to the use of clinical signs for predicting
hypoxaemia.25-27 Pulse oximetry is too costly for many
hospitals in developing countries, therefore the selection of patients
for referral or oxygen therapy has to be based on practical clinical
signs that can be recognised readily by health workers with minimal
expertise. Models that rely on the presence of cyanosis are not
practical because of difficulties in assessing this sign. In
circumstances where cyanosis may not be correctly assessed, the
presence of head nodding, the inability to cry, and a respiratory rate
90 breaths/min are useful ways of predicting hypoxaemia.
Children with lower respiratory tract infections caused by invasive bacteria usually present with more severe disease than those with upper respiratory tract infections caused by viruses. Our data suggest that children with respiratory disease caused by invasive bacteria are more at risk of hypoxaemia than those with disease caused by respiratory syncytial virus. This is a surprising finding as clinical experience suggests that severe infection with respiratory syncytial virus is a common cause of hypoxaemia in infants.
Our study has shown that clinical signs requiring minimal basic skills
and training to recognise can be used for formulating guidelines on the
rational use of oxygen. These signs can also be used to identify those
children with an acute lower respiratory tract infection requiring
referral to a specialist centre.
| |
Acknowledgments |
|---|
We thank nursing staff from the Royal Victoria Hospital and Medical Research Council Laboratories for the care of the children, and Drs Ayo Palmer, Mariatou Jallow, Godwin Enwere, Abiodun Adegunloye, Tumani Corrah, and Anthony Juwah for contributing to the children's management.
Contributors: MW initiated the research and helped design the study protocol. KM, the principal investigator of the Hib vaccine trial, helped design the study protocol. BG participated in the design of the study, and interpreted and reviewed the paper. AO, CO, and SU were involved with the design and execution of the study, data collection, data documentation, and clinical evaluation of the children. SJ and SU were involved with analysis and interpretation of data. RA performed the microbiological tests and also participated in the review of the paper. The paper was written jointly by SU, MW, KM, SJ, and BG. SU and MW will act as guarantors for the paper.
Funding: SJ is supported by an MRC grant. The vaccine trial was funded by the United States Agency for International Development Public Health Interagency for Vaccine Development and Health Research, the World Health Organisation programme for control of acute respiratory infections, the United Nations Children's Fund (Unicef), the Children's Initiative, and the United Nations development programme.
Conflict of interest: None.
| |
References |
|---|
|
|
|---|
(Accepted 28 October 1998)
Read all Rapid Responses